Market Trends of China Mammography Industry
Specialty Clinics Segment is Expected to Hold a Significant Market Share Over the Forecast Period
- The high prevalence of breast cancer cases and strategic initiatives by the major clinics are expected to boost market growth and large investments in healthcare expenditure. Additionally, awareness programs are also expected to boost market growth.
- According to the news published in March 2021, 400,000 Chinese women will develop breast cancer every year. Thus, the number of individuals requesting mammography screenings at clinics across China is anticipated to climb as breast cancer cases rise. This is anticipated to accelerate the segment expansion over the forecast period.
- Furthermore, the launch of breast clinic services in China is expected to drive segment growth over the forecast period due to the increased adoption of mammography services. For instance, in June 2021, Jiahui Breast Institute, a breast clinic, offered breast health outpatient services, including breast health screening through mammograms.
- Therefore, it is anticipated that the aforementioned improvements will further enhance the market growth in this sector.
Understand The Key Trends Shaping This Market
Download PDF
Breast Tomosynthesis is Expected to Grow with a Healthy CAGR in the Market Studied Over the Forecast Period.
- Breast tomosynthesis is a technologically advanced form of breast imaging that decreases the confounding effect of overlapping tissue and helps in improved lesion detection, characterization, and localization of tumors effectively.
- Based on advancements in both screening and diagnostic imaging outcomes, digital breast tomosynthesis (DBT) is becoming the standard for breast imaging. The additional information obtained from the tomosynthesis decreases the confounding effect of overlapping tissue, allowing for improved lesion detection, characterization, and localization. Also, compared to only using two-dimensional full-field digital mammography for imaging, the reconstructed DBT data set's quasi-three-dimensional information enables a more effective imaging work-up.
- According to the study published in the British Journal of Radiology in March 2021 in China, in younger women with thicker breasts, full-field digital mammography (FFDM) has limited sensitivity for malignancy. Therefore, Digital breast tomosynthesis (DBT) can reduce the risk of cancer being obscured by overlying tissue in such instances. The diverse advantages of DBT in patients with thick breast is expected to propel the segment growth over the forecast period.
- Rising awareness among the people due to the campaigns is expected to drive the segment studied over the forecast period. For instance, in March 2021, Beijing hosted the 5th Breast Cancer Endowment Management Chief Expert Forum and the 2021 China Cancer Health Management Conference. During the event, the Healthy China Breast Cancer Key Decade Action (HC-ABC Project) was formally launched at the conference, focusing on standardizing diagnosis and treatment to improve breast cancer patient survival over the next ten years. This will be achieved by enhancing homogenous diagnosis and treatment as well as standardized diagnosis and therapy. During the projected period, initiatives like these are anticipated to enhance segment growth since more patients may request standard mammography screening such as DBT.
- Therefore, the rising awareness of breast cancer screening and the rising benefits of DBT are the factors anticipated to drive the segment growth.
